AU Stocks
US Stocks
US Options
Emerging Asia
Cash Management
Margin Lending
Smart Portfolio
MoneybullN
NPCE
Neuropace Inc
7.98
-0.19-2.33%After Hours: 7.98 0.00 0.00%16:00 05/20 EDT
OPEN/PREV CLOSE8.16/8.17
TODAY RANGE7.88-8.28
VOL72.71K
MARKET CAP229.57M
52 WEEK RANGE3.800-18.15
AVG VOL (3M)121.09K
% TURNOVER0.25%
TURNOVER0
P/E (TTM)-6.7404
% RANGE4.90%
EPS(TTM)-1.1839
P/E(FORWARD)-6.8793
P/B15.98
BVPS0.4994
DIVIDEND--
P/S3.394
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP156.77M
SHARES OUTSTANDING28.77M
NEXT EARNINGS08/06-08/12
FREE FLOAT19.64M
LOT SIZE1
EX-DIV DATE--
News
Press Releases
Financial Reports
Profile
Press release·05/10 07:41
Neuropace, Inc. Quarterly Report on Form 10-Q for the Quarter Ended March 31, 2024
Seeking Alpha·05/09 17:12
CCLD, SKYT and SEED among mid-day movers
Benzinga·05/09 16:31
12 Health Care Stocks Moving In Thursday's Intraday Session
Dow Jones·05/09 15:19
NeuroPace Price Target Maintained With a $18.00/Share by Cantor Fitzgerald
Benzinga·05/09 15:09
Cantor Fitzgerald Reiterates Overweight on NeuroPace, Maintains $18 Price Target
Investorplace·05/09 00:55
NPCE Stock Earnings: NeuroPace Meets EPS, Beats Revenue for Q1 2024
Benzinga·05/08 21:23
NeuroPace Maintains FY24 Revenue Guidance Of $73M-$77M, Est $75.205M
Seeking Alpha·05/08 20:28
NeuroPace GAAP EPS of -$0.32
NASDAQ·05/07 21:30
Globus Medical (GMED) Q1 Earnings and Revenues Beat Estimates
TipRanks·05/06 12:55
Lake Street Sticks to Its Buy Rating for NeuroPace (NPCE)
TipRanks·04/04 13:20
‘Time to Hit Buy,’ Says Wells Fargo About These 2 Stocks
Same Industry
Name/Symbol
Change%
Price